May 3 (Reuters) - Abbott Laboratories:
* ABBOTT EXPANDS CARDIAC ARRHYTHMIAS PORTFOLIO WITH FDA CLEARANCE OF ADVANCED MAPPING CATHETER
* ABBOTT LABORATORIES - EXPECTS ADVISOR HD GRID COMMERCIAL USE TO BEGIN ACROSS U.S. IN COMING MONTHS Source text for Eikon: Further company coverage: